Drug Buyers' Retooled $34M Celgene Deal Wins Initial OK
A New Jersey federal judge has given the preliminary green light to a $34 million deal between drug buyers and Bristol-Myers Squibb unit Celgene over allegations the drugmaker illegally monopolized a...To view the full article, register now.
Already a subscriber? Click here to view full article